Chief Executive Officer
Shaun was appointed CEO of Indivior in 2014. Since 2009, Shaun led the Reckitt Benckiser Pharmaceuticals (RBP) business as CEO with a remit to build a global company through the acquisition of the global marketing rights from Merck, and he ensured its successful integration to accelerate RBP towards its vision. He has spearheaded the successful growth and development of RBP since launching the US Suboxone business in 2003. Following his formal appointment as President of RBP in 2005, Shaun led RBP through sustained growth, building a lifecycle management pipeline and expanded addiction franchise that grew from zero to a peak of $1.5 billion in net revenue. Today, under his leadership, Indivior successfully operates in 46 countries around the world.
Shaun joined Reckitt & Colman in 1995 as Senior Brand Manager and advanced to Category Manager within the Company’s UK Healthcare business. Following the 1999 merger with Benckiser, he was appointed Global Category Manager for the prescription product portfolio.
Shaun graduated from Kings College, London with a Joint Honors B.S. in biochemistry and physiology and undertook his early career with Proctor & Gamble and London International Group.